SEC Form 4 · accession 0001209191-17-049877
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aditya P. Mohanty
Officer — Co-Chief Executive Officer · Director
Period of report
Aug 21, 2017
Accepted (ET)
Aug 22, 2017 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1 | Aug 21, 2017 | P | 7,500 | $2.50 | A | 89,696 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Does not include Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options.